Suppr超能文献

拉丁裔结直肠癌患者的DNA错配修复缺陷与遗传综合征

DNA mismatch repair deficiency and hereditary syndromes in Latino patients with colorectal cancer.

作者信息

Ricker Charité N, Hanna Diana L, Peng Cheng, Nguyen Nathalie T, Stern Mariana C, Schmit Stephanie L, Idos Greg E, Patel Ravi, Tsai Steven, Ramirez Veronica, Lin Sonia, Shamasunadara Vinay, Barzi Afsaneh, Lenz Heinz-Josef, Figueiredo Jane C

机构信息

Department of Medicine, Division of Medical Oncology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California.

Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California.

出版信息

Cancer. 2017 Oct 1;123(19):3732-3743. doi: 10.1002/cncr.30790. Epub 2017 Jun 22.

Abstract

BACKGROUND

The landscape of hereditary syndromes and clinicopathologic characteristics among US Latino/Hispanic individuals with colorectal cancer (CRC) remains poorly understood.

METHODS

A total of 265 patients with CRC who were enrolled in the Hispanic Colorectal Cancer Study were included in the current study. Information regarding CRC risk factors was elicited through interviews, and treatment and survival data were abstracted from clinical charts. Tumor studies and germline genetic testing results were collected from medical records or performed using standard molecular methods.

RESULTS

The mean age of the patients at the time of diagnosis was 53.7 years (standard deviation, 10.3 years), and 48.3% were female. Overall, 21.2% of patients reported a first-degree or second-degree relative with CRC; 3.4% met Amsterdam I/II criteria. With respect to Bethesda guidelines, 38.5% of patients met at least 1 criterion. Of the 161 individuals who had immunohistochemistry and/or microsatellite instability testing performed, 21 (13.0%) had mismatch repair (MMR)-deficient (dMMR) tumors. dMMR tumors were associated with female sex (61.9%), earlier age at the time of diagnosis (50.4 ± 12.4 years), proximal location (61.9%), and first-degree (23.8%) or second-degree (9.5%) family history of CRC. Among individuals with dMMR tumors, 13 (61.9%) had a germline MMR mutation (MutL homolog 1 [MLH1] in 6 patients; MutS homolog 2 [MSH2] in 4 patients; MutS homolog 6 [MHS6] in 2 patients; and PMS1 homolog 2, mismatch repair system component [PMS2] in 1 patient). The authors identified 2 additional MLH1 mutation carriers by genetic testing who had not received immunohistochemistry/microsatellite instability testing. In total, 5.7% of the entire cohort were confirmed to have Lynch syndrome. In addition, 6 individuals (2.3%) had a polyposis phenotype.

CONCLUSIONS

The percentage of dMMR tumors noted among Latino individuals (13%) is similar to estimates in non-Hispanic white individuals. In the current study, the majority of individuals with dMMR tumors were confirmed to have Lynch syndrome. Cancer 2017. © 2017 The Authors. Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society. Cancer 2017;123:3732-3743. © 2017 American Cancer Society.

摘要

背景

美国拉丁裔/西班牙裔结直肠癌(CRC)患者的遗传性综合征及临床病理特征仍鲜为人知。

方法

本研究纳入了265例参与西班牙裔结直肠癌研究的CRC患者。通过访谈获取CRC危险因素信息,并从临床病历中提取治疗及生存数据。肿瘤研究及种系基因检测结果从医疗记录中收集或采用标准分子方法进行检测。

结果

患者诊断时的平均年龄为53.7岁(标准差10.3岁),48.3%为女性。总体而言,21.2%的患者报告有一级或二级亲属患CRC;3.4%符合阿姆斯特丹I/II标准。根据贝塞斯达指南,38.5%的患者至少符合1条标准。在161例进行免疫组化和/或微卫星不稳定性检测的患者中,21例(13.0%)存在错配修复(MMR)缺陷(dMMR)肿瘤。dMMR肿瘤与女性性别(61.9%)、诊断时年龄较早(50.4±12.4岁)、肿瘤位于近端(61.9%)以及CRC的一级(23.8%)或二级(9.5%)家族史相关。在患有dMMR肿瘤的个体中,13例(61.9%)存在种系MMR突变(6例为MutL同源物1[MLH1];4例为MutS同源物2[MSH2];2例为MutS同源物6[MHS6];1例为PMS1同源物2,错配修复系统成分[PMS2])。作者通过基因检测又发现了2例未接受免疫组化/微卫星不稳定性检测的MLH1突变携带者。整个队列中共有5.7%被确诊患有林奇综合征。此外,6例个体(2.3%)具有息肉病表型。

结论

拉丁裔个体中dMMR肿瘤的比例(13%)与非西班牙裔白人个体的估计值相似。在本研究中,大多数患有dMMR肿瘤的个体被确诊患有林奇综合征。《癌症》2017年。©2017作者。《癌症》由威利期刊公司代表美国癌症协会出版。《癌症》2017;123:3732 - 3743。©2017美国癌症协会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ce4/5637923/099ff2334cc9/CNCR-123-3732-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验